Science Explorer Back to mapMap
Discussion
Company · Waltham · United States

Repligen (United States)

repligen.comROR OpenAlex
World rank, all time
#28,954
of 34,923
Rank in United States
#6,092
of 7,310
Research works
217
▲ 238% vs 2018-21
Citations
12k
53.8 per fractional work
Top-10% rate
14.6%
all institutions 10.0%
vs its own fields
1.05×
1.00× is exactly expected
Open access
34%
world 40%
International
14%
world 18%
Repligen (United States)

Which fields of science does Repligen (United States) work in?

In 2022-now, 49% of research at Repligen (United States) is in Health Sciences, 45% in Life Sciences. Its largest fields are Medicine (45%), Biochemistry, Genetics and Molecular Biology (40%), Immunology and Microbiology (5%). It does 2.7× the world's share of Life Sciences.

Health Sciences: 27 fractional works · 48.6% of its workMedicine: 24 fractional works · 44.7% of its workOncology: 7 fractional works · 12.4% of its workPulmonary and Respiratory Medicine: 5 fractional works · 9.9% of its workPathology and Forensic Medicine: 4 fractional works · 7.9% of its workRadiology, Nuclear Medicine and Imaging: 2 fractional works · 3.9% of its workGenetics: 1 fractional works · 2.7% of its workHematology: 1 fractional works · 1.5% of its workSurgery: 1 fractional works · 1.3% of its workHepatology: 1 fractional works · 1.2% of its workDermatology: 0 fractional works · 0.6% of its workNeurology: 0 fractional works · 0.6% of its workEpidemiology: 0 fractional works · 0.5% of its workInfectious Diseases: 0 fractional works · 0.5% of its workHealth Informatics: 0 fractional works · 0.2% of its workComplementary and alternative medicine: 0 fractional works · 0.2% of its workObstetrics and Gynecology: 0 fractional works · 0.2% of its workOrthopedics and Sports Medicine: 0 fractional works · 0.2% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.6% of its workHealth Professions: 2 fractional works · 3.7% of its workGeneral Health Professions: 2 fractional works · 2.7% of its workHealth Information Management: 0 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.1% of its workDentistry: 0 fractional works · 0.2% of its workOral Surgery: 0 fractional works · 0.2% of its workLife Sciences: 25 fractional works · 45.1% of its workBiochemistry, Genetics and Molecular Biology: 22 fractional works · 39.5% of its workMolecular Biology: 14 fractional works · 25.5% of its workCancer Research: 6 fractional works · 11.0% of its workGenetics: 1 fractional works · 1.8% of its workStructural Biology: 0 fractional works · 0.6% of its workBiophysics: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 3 fractional works · 5.2% of its workImmunology: 2 fractional works · 4.6% of its workMicrobiology: 0 fractional works · 0.6% of its workAgricultural and Biological Sciences: 0 fractional works · 0.2% of its workNeuroscience: 0 fractional works · 0.2% of its workPhysical Sciences: 3 fractional works · 4.8% of its workEngineering: 1 fractional works · 2.1% of its workBiomedical Engineering: 1 fractional works · 1.0% of its workComputational Mechanics: 0 fractional works · 0.6% of its workMechanical Engineering: 0 fractional works · 0.3% of its workAerospace Engineering: 0 fractional works · 0.2% of its workComputer Science: 1 fractional works · 1.9% of its workArtificial Intelligence: 1 fractional works · 1.3% of its workComputational Theory and Mathematics: 0 fractional works · 0.3% of its workComputer Vision and Pattern Recognition: 0 fractional works · 0.3% of its workMaterials Science: 0 fractional works · 0.3% of its workMaterials Chemistry: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workChemistry: 0 fractional works · 0.2% of its workAnalytical Chemistry: 0 fractional works · 0.2% of its workPhysics and Astronomy: 0 fractional works · 0.2% of its workRadiation: 0 fractional works · 0.2% of its workMathematics: 0 fractional works · 0.0% of its workSocial Sciences: 1 fractional works · 1.5% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.6% of its workEconomics and Econometrics: 0 fractional works · 0.6% of its workSocial Sciences: 0 fractional works · 0.6% of its workHealth: 0 fractional works · 0.3% of its workSociology and Political Science: 0 fractional works · 0.3% of its workArts and Humanities: 0 fractional works · 0.3% of its workALL ITS WORKRepligen (UnitedStates)55fractional works, 2022-now
Life Sciences45%Physical Sciences5%Health Sciences49%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 16 fields, with their numbers
    1. Medicine2444.7%
    2. Health Professions23.7%
    3. Dentistry00.2%
    1. Biochemistry, Genetics and Molecular Biology2239.5%
    2. Immunology and Microbiology35.2%
    3. Agricultural and Biological Sciences00.2%
    4. Neuroscience00.2%
    1. Engineering12.1%
    2. Computer Science11.9%
    3. Materials Science00.3%
    4. Chemistry00.2%
    5. Physics and Astronomy00.2%
    6. Mathematics00.0%
    1. Economics, Econometrics and Finance00.6%
    2. Social Sciences00.6%
    3. Arts and Humanities00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does Repligen (United States) specialise in?

Where its research is concentrated relative to its size: Biochemistry, Genetics and Molecular Biology takes 7.4× the share of its output that it takes of world research.

  1. Biochemistry, Genetics and Molecular BiologyField · 21.6 works7.4×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.05× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 7.41× its world share, 22 worksBiochemistry, Geneti…Immunology and Microbiology: 5.12× its world share, 3 worksImmunology and Micro…Neuroscience: 0.13× its world share, 0 worksNeuroscienceChemistry: 0.13× its world share, 0 worksChemistryComputer Science: 0.25× its world share, 1 worksComputer ScienceEngineering: 0.14× its world share, 1 worksEngineeringMaterials Science: 0.09× its world share, 0 worksMaterials ScienceMathematics: 0.04× its world share, 0 worksMathematicsPhysics and Astronomy: 0.09× its world share, 0 worksPhysics and AstronomyDentistry: 0.42× its world share, 0 worksDentistryHealth Professions: 1.41× its world share, 2 worksHealth ProfessionsMedicine: 2.32× its world share, 24 worksMedicineArts and Humanities: 0.11× its world share, 0 worksArts and HumanitiesEconomics, Econometrics and Finance: 0.28× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.05× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 7.4×. Every wedge is a field page.

All 16 fields, with their numbers
  1. Biochemistry, Genetics and Molecular Biology7.41×22 works
  2. Immunology and Microbiology5.12×3 works
  3. Medicine2.32×24 works
  4. Health Professions1.41×2 works
  5. Dentistry0.42×0 works
  6. Economics, Econometrics and Finance0.28×0 works
  7. Computer Science0.25×1 works
  8. Engineering0.14×1 works
  9. Neuroscience0.13×0 works
  10. Chemistry0.13×0 works
  11. Arts and Humanities0.11×0 works
  12. Materials Science0.09×0 works
  13. Physics and Astronomy0.09×0 works
  14. Agricultural and Biological Sciences0.05×0 works
  15. Social Sciences0.05×0 works
  16. Mathematics0.04×0 works

Who are the top researchers at Repligen (United States)?

Ranked on the quality score, G S Gray, Scott D. Putney and James R. Rusche lead among researchers whose main affiliation is Repligen (United States).

  1. 1 G S Gray United States · #206,304 worldwide 5.7k citations · 40 works
  2. 2 Scott D. Putney United States · #227,920 worldwide 7.9k citations · 73 works
  3. 3 James R. Rusche United States · #433,453 worldwide 4.7k citations · 66 works
  4. 4 Gary S. Gray United States · #760,298 worldwide 6.3k citations · 37 works
  5. 5 J R Rusche United States · #952,550 worldwide 3.4k citations · 29 works
  6. 6 Thomas J. Daly United States · #1,290,078 worldwide 1.6k citations · 28 works
  7. 7 Maria V. Tsiper United States · #1,578,745 worldwide 2.1k citations · 40 works
  8. 8 Theodore E. Maione United States · #1,580,754 worldwide 2.3k citations · 29 works
  9. 9 Alan J. Hutchison United States · #1,923,324 worldwide 943 citations · 29 works
  10. 10 Sandra Silver United States · #2,063,660 worldwide 1.1k citations · 22 works
All ranked researchers at Repligen (United States)

What are the most cited papers from Repligen (United States)?

The most cited paper from Repligen (United States) is "Cloning of B7-2: a CTLA-4 Counter-Receptor That Costimulates Human T Cell Proliferation" (Gordon James Freeman, John G. Gribben, Vassiliki A. Boussiotis et al., 1993), with 920 citations. Next come "Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides" (708) and "Conserved Sequence and Structural Elements in the HIV-1 Principal Neutralizing Determinant" (655).

Most cited papers
#PaperReleasedCitations
1 Cloning of B7-2: a CTLA-4 Counter-Receptor That Costimulates Human T Cell Proliferation Gordon James Freeman, John G. Gribben, Vassiliki A. Boussiotis et al. · Science 5 Nov 1993 920
2 Inhibition of Angiogenesis by Recombinant Human Platelet Factor-4 and Related Peptides Theodore E. Maione, Gary S. Gray, Joan Petro et al. · Science 5 Jan 1990 708
3 Conserved Sequence and Structural Elements in the HIV-1 Principal Neutralizing Determinant Gregory J. LaRosa, Joseph P. Davide, Kent J. Weinhold et al. · Science 24 Aug 1990 655
4 Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. J R Rusche, Kashi Javaherian, Charlene B. McDanal et al. · Proceedings of the National Academy of Sciences Open access May 1988 624
5 Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Kashi Javaherian, A J Langlois, Charlene B. McDanal et al. · Proceedings of the National Academy of Sciences Open access Sep 1989 620
All 60 most cited papers, with filters and sorting

Which keywords describe research at Repligen (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Gene Expression, Lymphoma, Tumor Microenvironment, Rituximab, Targeted Therapy, Immunotherapy, Genomic Instability and Cancer Genomics.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Gene Expression6▲ 19×7 topics
  2. Lymphoma6▲ 69×3 topics
  3. Rituximab5▲ 61×2 topics
  4. Tumor Microenvironment5▲ 20×5 topics
  5. Targeted Therapy5▲ 40×4 topics
  6. Immunotherapy5▲ 12×8 topics
  7. Cancer4▲ 6.1×10 topics
  8. Genomic Instability4▲ 71×2 topics
  9. Cancer Genomics4▲ 110×1 topic
  10. Mutational Signatures4▲ 110×1 topic
  11. Gene Expression Profiling4▲ 91×2 topics
  12. Molecular Profiling4▲ 75×2 topics
  13. PET Imaging4▲ 42×3 topics
  14. Prognostic Factors4▲ 16×7 topics
  15. Classification4▲ 15×1 topic
  16. Genetic Pathogenesis4▲ 127×1 topic
  17. Data Analysis3▲ 23×4 topics
  18. Chemotherapy3▲ 8.1×9 topics
  19. Glycosylation3▲ 53×2 topics
  20. Monoclonal Antibodies3▲ 64×3 topics
  21. Therapeutic Antibodies3▲ 80×2 topics
  22. Normalization3▲ 102×2 topics
  23. Cancer Immunotherapy3▲ 31×3 topics
  24. Immune Checkpoint Blockade2▲ 40×1 topic
  25. PD-1 and PD-L12▲ 40×1 topic
  26. Leukemia2▲ 52×2 topics
  27. Biomarkers2▲ 5.8×7 topics
  28. Clinical Practice Guidelines2▲ 7.0×4 topics
  29. Quantitative2▲ 43×1 topic
  30. Real-Time PCR2▲ 151×1 topic
  31. CAR T Cells2▲ 50×1 topic
  32. Cell Death2▲ 15×3 topics
  33. Chimeric Antigen Receptor2▲ 50×1 topic
  34. Monoclonal Antibody2▲ 62×2 topics
  35. Biopharmaceuticals2▲ 62×3 topics
  36. Ferroptosis2▲ 38×1 topic
  37. Immunogenicity2▲ 70×2 topics
  38. Lipid Peroxidation2▲ 28×1 topic
  39. Mammalian Cells2▲ 133×1 topic
  40. Recombinant Protein2▲ 133×1 topic

Which research topics does Repligen (United States) publish most on?

By volume in 2022-now: Cancer Genomics and Diagnostics, Lymphoma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers and Molecular Biology Techniques and Applications.

Cancer Genomics and Diagnostics: 4 fractional worksLymphoma Diagnosis and Treatment: 4 fractional worksCancer Immunotherapy and Biomarkers: 2 fractional worksMolecular Biology Techniques and Applications: 2 fractional worksCAR-T cell therapy research: 2 fractional worksFerroptosis and cancer prognosis: 2 fractional worksViral Infectious Disease…2Viral Infectious Diseases and Gene Expression in Insects: 2 fractional worksProtein purification and stability: 2 fractional worksMonoclonal and Polyclonal Antibodies Research: 2 fractional worksSingle-cell and spatial transcriptomics: 2 fractional works
Cancer ResearchPathology and Forensic MedicineOncologyMolecular Biology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer Genomics and Diagnostics Cancer Research 4 works
  2. 2 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 4 works
  3. 3 Cancer Immunotherapy and Biomarkers Oncology 2 works
  4. 4 Molecular Biology Techniques and Applications Molecular Biology 2 works
  5. 5 CAR-T cell therapy research Oncology 2 works
  6. 6 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 2 works
  7. 7 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 2 works
  8. 8 Protein purification and stability Molecular Biology 2 works
  9. 9 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
  10. 10 Single-cell and spatial transcriptomics Molecular Biology 2 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available33.9%not open66.1%

World: 40% of research is openly available.

with international co-authors14.0%domestic only86.0%

World: 18% is written across borders.

How has Repligen (United States)'s research output changed?

Output in 2022-2025 was 238% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Repligen (United States) as a percentage of every work published that year, 0.00024% in 2024.

still counting0.0010%0.0020%Repligen (United States)0.00023% in 202519801990200020102020

Fractional works of Repligen (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Waltham

All research institutions in Waltham

Share Repligen (United States)'s ranking

Repligen (United States) on Science Explorer

A card with Repligen (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Repligen (United States). Posts are plain text and can be reported.